日本語English简体中文 繁體中文

4527 ROHTO PHARMACEUTICAL CO.,LTD.ロート製薬TSE Prime / Pharmaceuticals

0 posts

ROHTO PHARMACEUTICAL CO.,LTD. (4527) at a glance

Code
4527
Company
ROHTO PHARMACEUTICAL CO.,LTD.
Local name
ロート製薬
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥2,632 -30.0 (-1.13%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

ROHTO PHARMACEUTICAL CO.,LTD. (4527) Stock Price History

ROHTO PHARMACEUTICAL CO.,LTD. closed at ¥2,632 on Nov 20, 2026, −9.7% over 1 month, +6.0% over 1 year.

2026-11-12 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)¥2,913¥2,446Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥2,913Oct 20
1-Month Low¥2,446Nov 13
1-Week Change+7.6%vs Nov 13
1-Month Change−9.7%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥90,336 today (−9.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −9.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,632−30−1.13%
Nov 19 (Thu)¥2,662+18.5+0.70%
Nov 18 (Wed)¥2,643−11−0.41%
Nov 17 (Tue)¥2,654+70+2.71%
Nov 16 (Mon)¥2,584+138.5+5.66%
Nov 13 (Fri)¥2,446−241−8.97%
Nov 12 (Thu)¥2,687+57.5+2.19%
Nov 11 (Wed)¥2,629−133−4.82%
Nov 10 (Tue)¥2,762−18−0.65%
Nov 9 (Mon)¥2,780+84+3.12%
2026-11-12 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)¥3,106¥2,446Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥3,106Aug 28
3-Month Low¥2,446Nov 13
1-Month Change−9.7%vs Oct 20
3-Month Change−8.2%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥91,786 today (−8.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −8.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,632−30−1.13%
Nov 19 (Thu)¥2,662+18.5+0.70%
Nov 18 (Wed)¥2,643−11−0.41%
Nov 17 (Tue)¥2,654+70+2.71%
Nov 16 (Mon)¥2,584+138.5+5.66%
Nov 13 (Fri)¥2,446−241−8.97%
Nov 12 (Thu)¥2,687+57.5+2.19%
Nov 11 (Wed)¥2,629−133−4.82%
Nov 10 (Tue)¥2,762−18−0.65%
Nov 9 (Mon)¥2,780+84+3.12%
2026-11-12 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)¥3,106¥2,279May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥3,106Aug 28
6-Month Low¥2,279Jun 15
3-Month Change−8.2%vs Aug 20
6-Month Change+3.4%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥103,379 today (+3.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved +3.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,632−4.0%
Oct 2026¥2,740−2.5%
Sep 2026¥2,809−8.1%
Aug 2026¥3,055+27.9%
Jul 2026¥2,389+0.1%
Jun 2026¥2,387+0.3%
May 2026¥2,381+3.5%
2026-11-12 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(連結)¥3,106¥2,251Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥3,106Aug 28
52-Week Low¥2,251Mar 5
Year to Date+0.1%vs Dec 30
From 52-Week High−15.3%Aug 28

If you had invested ¥100,000 1 year ago, it would be worth ¥106,023 today (+6.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +6.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,632−4.0%
Oct 2026¥2,740−2.5%
Sep 2026¥2,809−8.1%
Aug 2026¥3,055+27.9%
Jul 2026¥2,389+0.1%
Jun 2026¥2,387+0.3%
May 2026¥2,381+3.5%
Apr 2026¥2,301−4.4%
Mar 2026¥2,408−1.4%
Feb 2026¥2,442−4.5%
Jan 2026¥2,558−2.7%
Dec 2025¥2,628+3.9%
Nov 2025¥2,531―
¥3,669¥1,984Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥3,669Sep 23, 2024
3-Year Low¥1,984Jun 2, 2025
Annualized Return−6.4%
Max Drawdown−45.9%

If you had invested ¥100,000 3 years ago, it would be worth ¥82,106 today (−17.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −17.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,632+0.1%
2025¥2,628―
¥4,060¥1,573Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥4,060Sep 11, 2023
5-Year Low¥1,573Jan 24, 2022
Annualized Return+9.4%
Max Drawdown−51.1%

If you had invested ¥100,000 5 years ago, it would be worth ¥156,870 today (+56.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved +56.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,632+0.1%
2025¥2,628―
¥4,055¥185Feb 1, 2001Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥4,055Sep 2023
All-Time Low¥185Dec 2001
Total Change+785.3%vs Feb 2001
Annualized Return+8.8%

If you had invested ¥100,000 in Feb 2001, it would be worth ¥885,282 today (+785.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +334.1%, while this stock moved +785.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,632+0.1%
2025¥2,628−8.7%
2024¥2,878+1.2%
2023¥2,843+22.5%
2022¥2,320+33.5%
2021¥1,738+13.7%
2020¥1,528−8.0%
2019¥1,660+10.7%
2018¥1,500−0.3%
2017¥1,505+63.8%
2016¥919−24.1%
2015¥1,211+60.9%
2014¥753−6.2%
2013¥803+59.4%
2012¥504+1.7%
2011¥495+4.3%
2010¥475−11.3%
2009¥535−13.9%
2008¥622−0.3%
2007¥624+1.5%
2006¥614+3.8%
2005¥592+75.1%
2004¥338+51.1%
2003¥224+10.0%
2002¥203+10.0%
2001¥185―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2001). Please check the latest prices before trading.

ROHTO PHARMACEUTICAL CO.,LTD. (4527) financial indicators

PER
16.8
PBR
1.88
ROE
11.17%
Dividend yield
1.90%

See all financial indicators for ROHTO PHARMACEUTICAL CO.,LTD. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Business overview

Together with 115 subsidiaries and 18 affiliates, the company makes and sells products and services mainly in health and beauty care: eye care (eye drops, eye washes and more), skin care (topical drugs, lip balm, sunscreen, functional cosmetics and more), oral and food products (gastrointestinal medicines, Kampo medicines, supplements and more), medical (CDMO business, prescription ophthalmic drugs and more) and others (in vitro diagnostics and more). Its segments are regional: Japan, the Americas, Europe and Asia. In Japan the company handles all fields, with 「ロートニッテン」 and 「クオリテックファーマ」 handling medical products. In the Americas and Europe, Mentholatum and others make and sell mainly skin care products, and in Asia, Mentholatum Asia Pacific and others make and sell mainly eye care and skin care products.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield1.90%No. 31 in the sector (highest first); median 2.97%
PER16.8xAbove the sector median of 16.5x (No. 18 from the lowest)
PBR1.88xAbove the sector median of 1.86x (No. 39 from the lowest)
ROE11.17%No. 11 in the sector (highest first); median 4.17%
Market cap¥591.9 bnNo. 12 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3,1068/28
52-week low¥2,2513/5
Current position44.5%Where the low is 0% and the high is 100% (close on 11/20: ¥2,632)
Year to date+0.1%No. 17 of 77 in the sector (best first)
1 year+6.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 losers1 timesLatest: 11/13 (No. 35)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (6).

Shareholder benefits of ROHTO PHARMACEUTICAL CO.,LTD.

Program status
Active
Record month
March
Minimum shares
100 shares or more
Benefit
Kokorohto Park points or company products (worth ¥2,000 to ¥20,000)

Details and disclosure history of ROHTO PHARMACEUTICAL CO.,LTD.'s shareholder benefits

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the ROHTO PHARMACEUTICAL CO.,LTD. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English